pubmed-article:6986242 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C0681867 | lld:lifeskim |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C0013295 | lld:lifeskim |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C0008783 | lld:lifeskim |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C1880019 | lld:lifeskim |
pubmed-article:6986242 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
pubmed-article:6986242 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:6986242 | pubmed:dateCreated | 1980-4-25 | lld:pubmed |
pubmed-article:6986242 | pubmed:abstractText | Patients with a healed duodenal ulcer and who were symptom-free following 12 months of maintenance treatment with cimetidine 400 mg twice daily were randomized double-blind to a further 6 months therapy with either cimetidine 400 mg twice daily or placebo 2 tablets twice daily. Twenty-six patients received placebo and 15 patients cimetidine. Relapse was defined as symptoms for 3 out of 7 consecutive days and ulcer recurrence was confirmed by independent endoscopy. One of 15 patients on cimetidine relapsed: 20 of 26 patients on placebo relapsed. This relapse rate (77%) is similar to that found in previous studies after only 6 weeks cimetidine therapy (71%). This study suggests that 12 months cimetidine does not change the tendency of duodenal ulcer to recur and that the relapse rate is no greater than after 6 weeks cimetidine. | lld:pubmed |
pubmed-article:6986242 | pubmed:language | eng | lld:pubmed |
pubmed-article:6986242 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6986242 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:6986242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6986242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6986242 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6986242 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6986242 | pubmed:month | Feb | lld:pubmed |
pubmed-article:6986242 | pubmed:issn | 0163-2116 | lld:pubmed |
pubmed-article:6986242 | pubmed:author | pubmed-author:ShearmanD JDJ | lld:pubmed |
pubmed-article:6986242 | pubmed:author | pubmed-author:HanskyJJ | lld:pubmed |
pubmed-article:6986242 | pubmed:author | pubmed-author:HetzelD JDJ | lld:pubmed |
pubmed-article:6986242 | pubmed:author | pubmed-author:DonGG | lld:pubmed |
pubmed-article:6986242 | pubmed:author | pubmed-author:KormanM GMG | lld:pubmed |
pubmed-article:6986242 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6986242 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:6986242 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6986242 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6986242 | pubmed:pagination | 88-91 | lld:pubmed |
pubmed-article:6986242 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:meshHeading | pubmed-meshheading:6986242-... | lld:pubmed |
pubmed-article:6986242 | pubmed:year | 1980 | lld:pubmed |
pubmed-article:6986242 | pubmed:articleTitle | Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. | lld:pubmed |
pubmed-article:6986242 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6986242 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:6986242 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6986242 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6986242 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6986242 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6986242 | lld:pubmed |